The flu vaccine is working - Scorecard - MDSpire

The flu vaccine is working

  • By

  • O. Rose Broderick

  • January 16, 2026

  • 0 min

Share

Clinical Scorecard: Efficacy of the Influenza Vaccine Confirmed

At a Glance

CategoryDetail
ConditionInfluenza
Key MechanismsVaccination to stimulate immune response against influenza viruses.
Target PopulationGeneral population, particularly vulnerable groups during flu season.
Care SettingOutpatient settings, public health vaccination programs.

Key Highlights

  • Flu vaccine shows effectiveness against H3N2 subclade K.
  • UK and University of Pennsylvania research indicates vaccine offers protection.
  • French study reports vaccine effectiveness at 36%.
  • Chinese study shows vaccine effectiveness at 40% for H3N2.
  • Concerns about emerging virus mutations affecting vaccine efficacy.

Guideline-Based Recommendations

Diagnosis

  • Laboratory confirmation of influenza infection is recommended.

Management

  • Vaccination is recommended as a primary preventive measure.

Monitoring & Follow-up

  • Monitor vaccine effectiveness and emerging virus strains.

Risks

  • Potential reduced effectiveness against newly emerged virus strains.

Patient & Prescribing Data

Individuals eligible for seasonal influenza vaccination.

Vaccination remains a key strategy despite potential mutations.

Clinical Best Practices

  • Encourage annual flu vaccination for all eligible individuals.
  • Stay updated on emerging strains and adjust vaccination strategies accordingly.
  • Educate patients on the importance of vaccination even with varying effectiveness.

Related Resources & Content

Original Source(s)

The flu vaccine is working

  • by O. Rose Broderick

  • January 16, 2026

Related Content

Hydrocortisone May Lower Severe CAP Mortality

Network meta-analysis suggests hydrocortisone may offer mortality and ventilation benefits, although evidence certainty remained low.

Amoxicillin-Clavulanate vs Amoxicillin for Sinusitis

Amoxicillin-clavulanate was not linked to lower treatment failure but was associated with a slightly higher risk of secondary infections compared with amoxicillin in adults with uncomplicated acute sinusitis.

CDC Lists Dozens of Infectious Disease Tests as Unavailable

More than two dozen assays paused or discontinued, with alternative testing options noted